SWOT Analysis Reports & Company Profiles

Publications found: 164,030
Sort by:

Nabriva Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nabriva Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OncoMed Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoMed Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TG Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TG Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ADMA Biologics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ADMA Biologics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Altimmune Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Altimmune Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Chimerix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chimerix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

EyeGate Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

EyeGate Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tocagen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tocagen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Dermira, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Dermira, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ENDRA Life Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ENDRA Life Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regenxbio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regenxbio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Capricor Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Capricor Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Concert Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Concert Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novocure Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novocure Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Syndax Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Syndax Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aduro Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aduro Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bellicum Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bellicum Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

FibroGen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

FibroGen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ocular Therapeutix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ocular Therapeutix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Editas Medicine Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Editas Medicine Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PLx Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PLx Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Agios Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agios Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wave Life Sciences Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wave Life Sciences Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Karyopharm Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Karyopharm Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Phibro Animal Health Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phibro Animal Health Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ionis Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ionis Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Xenon Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xenon Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AnaptysBio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AnaptysBio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ANI Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ANI Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ProQR Therapeutics NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ProQR Therapeutics NV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vaxart, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vaxart, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Eagle Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Eagle Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Mediwound Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mediwound Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ascendis Pharma AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ascendis Pharma AS Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pulmatrix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pulmatrix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Quotient Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quotient Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aratana Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aratana Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cellular Biomedicine Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellular Biomedicine Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cerecor Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cerecor Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Natera Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Natera Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Theravance Biopharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Theravance Biopharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Blueprint Medicines Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Blueprint Medicines Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

GlycoMimetics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

GlycoMimetics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Millendo Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Millendo Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioverativ Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioverativ Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Molecular Templates Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Molecular Templates Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cara Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cara Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Seres Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Seres Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kalvista Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kalvista Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

7,665
6,761
4,993
4,645
4,328
4,036
3,979
3,241
3,083
2,925
2,713
2,595
2,125
2,024
2,008
1,654
1,587
1,254
1,158
1,091
982
791
789
572
494
493
304
1,542
9,254
3,983
67,744
8,589
1,186
3,442

Publishers

53,883
43,113
1,245
3
12
1
5
4
2
2
9
11,951
6
5
12,341
6
3
11,044
12
27
48
6
356
24,220
1
1,042
7
1
1,225
1,830
3
149
352
4
2
2
517
1
60

Regions

171
94
91
91
83
80
54
43
34
32
30
19
18
17
13
12
12
12
11
6
5
5
5
5
4
4
4
4
4
4
3
2
2
2
2
2
2
2
1
470
3
1
1
1
4,304
584
433
18
12
121
9
20
12
1
66
7
1
1,007
32
19
38
40
1
154
20
506
178
28,201
65
240
189
30
630
191
163
299
18
413
48
1,433
634
14
100
23
1,445
1
32
398
1
35
41
322
217
19
23
440
8
1
10
355
671
465
429
3,775
925
8,253
1,134
3
2,843
1,162
4
1
2
3,375
1,390
996
272
798
695
402
2,433
1,099
9,272
120
1,012
4,876
884
503
2
1,712
87
2
167
16
8,662
1,193
80
5,494
313
2,376
707
135
1
4
12
3
42,543
7,541

Price

—

Date

—

Pages

—

Offers